124 related articles for article (PubMed ID: 3942985)
21. The influence of initial residual disease on the outcome of second-look laparotomy in patients with carcinoma of the ovary.
Soeters RP; Bloch B; Dehaeck K; Levin W
Eur J Gynaecol Oncol; 1992; 13(3):223-7. PubMed ID: 1618220
[TBL] [Abstract][Full Text] [Related]
22. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
[TBL] [Abstract][Full Text] [Related]
24. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
[TBL] [Abstract][Full Text] [Related]
25. Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.
Podratz KC; Malkasian GD; Wieand HS; Cha SS; Lee RA; Stanhope CR; Williams TJ
Gynecol Oncol; 1988 Mar; 29(3):274-82. PubMed ID: 3345949
[TBL] [Abstract][Full Text] [Related]
26. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
27. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
29. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
[TBL] [Abstract][Full Text] [Related]
30. Predictors of recurrent disease after negative second-look laparotomy for epithelial ovarian cancer.
Ayhan A; Urman B; Yarali H; Yüce K; Ayhan A
J Surg Oncol; 1990 Jun; 44(2):119-21. PubMed ID: 2355741
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of second-look laparotomy for patients with epithelial ovarian carcinoma.
Kamura T; Tsukamoto N; Saito T; Kaku T; Matsuyama T; Nakano H
Int J Gynaecol Obstet; 1990 Oct; 33(2):141-7. PubMed ID: 1976547
[TBL] [Abstract][Full Text] [Related]
32. The second-look surgical reassessment for epithelial ovarian carcinoma.
Barnhill DR; Hoskins WJ; Heller PB; Park RC
Gynecol Oncol; 1984 Oct; 19(2):148-54. PubMed ID: 6489826
[TBL] [Abstract][Full Text] [Related]
33. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
34. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
35. Second-look operation in ovarian cancer.
Podratz KC; Kinney WK
Cancer; 1993 Feb; 71(4 Suppl):1551-8. PubMed ID: 8431893
[TBL] [Abstract][Full Text] [Related]
36. Is routine second-look laparotomy for ovarian cancer justified?
Sonnendecker EW
Gynecol Oncol; 1988 Oct; 31(2):249-55. PubMed ID: 3049261
[TBL] [Abstract][Full Text] [Related]
37. ACOG Committee opinion. Second-look laparotomy for epithelial ovarian cancer. Number 165, December 1995 (replaces no. 100, November 1991). Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
Int J Gynaecol Obstet; 1996 Apr; 53(1):81-3. PubMed ID: 8737312
[TBL] [Abstract][Full Text] [Related]
38. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Rose PG; Faulhaber P; Miraldi F; Abdul-Karim FW
Gynecol Oncol; 2001 Jul; 82(1):17-21. PubMed ID: 11426956
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the role of second-look surgery in ovarian cancer.
Chambers SK; Chambers JT; Kohorn EI; Lawrence R; Schwartz PE
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
[TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
